Abstract
Purpose:
To observe the curative effect of Xeloda in meibomian gland carcinoma.
Methods:
We treated a 53-year-old woman, who had recrudescent meibomian gland carcinoma, with Xeloda.
Results:
The mass was much smaller with decreased amount of overflow pus after 4 cycles of chemotherapy with Xeloda.
Conclusions:
Xeloda played a significant role in treating recrudescent meibomian gland carcinoma in this patient.
MeSH terms
-
Adenocarcinoma, Sebaceous / diagnostic imaging
-
Adenocarcinoma, Sebaceous / drug therapy*
-
Adenocarcinoma, Sebaceous / secondary
-
Antimetabolites, Antineoplastic / therapeutic use*
-
Capecitabine
-
Deoxycytidine / analogs & derivatives*
-
Deoxycytidine / therapeutic use
-
Eyelid Neoplasms / diagnostic imaging
-
Eyelid Neoplasms / drug therapy*
-
Eyelid Neoplasms / pathology
-
Female
-
Fluorouracil / analogs & derivatives*
-
Fluorouracil / therapeutic use
-
Humans
-
Lymphatic Metastasis
-
Meibomian Glands / diagnostic imaging
-
Meibomian Glands / drug effects*
-
Meibomian Glands / pathology
-
Middle Aged
-
Neoplasm Recurrence, Local / diagnostic imaging
-
Neoplasm Recurrence, Local / drug therapy*
-
Neoplasm Recurrence, Local / pathology
-
Prodrugs
-
Tomography, X-Ray Computed
-
Treatment Outcome
Substances
-
Antimetabolites, Antineoplastic
-
Prodrugs
-
Deoxycytidine
-
Capecitabine
-
Fluorouracil